Latest filing published 27 Jun 2022 for GlaxoSmithKline plc, €0.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James Ford: trading record in brief
This profile gathers the share dealings of James Ford in GlaxoSmithKline plc. Between 10 February 2022 and 28 April 2022, the trades on record add up to 4 filings.
Both buying and selling appear: 3 purchases worth €369k, against 1 sale worth €0. Taken together, the purchases exceed the sales by €369k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
A typical purchase (the median) is worth €71k.
The newest entry dates from 27 June 2022: an open-market sale of €0, in GlaxoSmithKline plc. The clock since the last published purchase (9 May 2022) now reads 1,645 days. The median gap between a trade and its publication by RNS (LSE) is 9 days. The legal deadline for notifying a trade is three business days (UK MAR). Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James Ford
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0.003 shares@ £18.8253London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4418811
- 3,347 shares@ £17.91London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4363545Canonical exit: 27 Jul 2022 (T+90)
- 15,360 shares@ £16.29London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4274550-0Canonical exit: 11 May 2022 (T+90)
- 46 shares@ US$42.93New York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:4274550-1Canonical exit: 15 May 2022 (T+90)
4 of 4 declarations